Gass Jennifer, Blackburn Patrick, Jackson Jessica, Harris Kimberly, Selcen Duygu, Dimberg Elliot, Atwal Paldeep
*Center for Individualized Medicine, Mayo Clinic, Jacksonville, FL; †Department of Clinical Genomics, Mayo Clinic, Jacksonville, FL; ‡Department of Neurology, Mayo Clinic, Rochester, MN; and §Department of Neurology, Mayo Clinic, Jacksonville, FL.
J Clin Neuromuscul Dis. 2017 Mar;18(3):152-156. doi: 10.1097/CND.0000000000000164.
Welander distal myopathy is a rare autosomal dominant disorder characterized by muscle weakness in the hands and feet. Exome sequencing of affected families discovered a segregating p.Glu384Lys pathogenic variant in TIA-1 as the main genetic cause of Welander distal myopathy. TIA-1 encodes an RNA-binding protein which serves as a key component of stress granules. This protein also regulates splicing and translation of mRNA. Our patient developed progressive weakness in his hands and feet during his late 40s that was misdiagnosed as a neuropathy that caused muscle atrophy. Follow-up genetic testing revealed a p.Glu384Lys pathogenic variant in TIA-1, and he was then diagnosed with Welander distal myopathy. Our case report underlines the importance of electrodiagnostic and genetic testing of patients.
韦兰德远端肌病是一种罕见的常染色体显性疾病,其特征是手脚肌肉无力。对患病家族进行外显子组测序发现,TIA-1基因中一个分离的p.Glu384Lys致病性变异是韦兰德远端肌病的主要遗传病因。TIA-1编码一种RNA结合蛋白,它是应激颗粒的关键组成部分。该蛋白还调节mRNA的剪接和翻译。我们的患者在40多岁后期出现了手脚渐进性无力,最初被误诊为导致肌肉萎缩的神经病变。后续的基因检测发现TIA-1基因存在p.Glu384Lys致病性变异,随后他被诊断为韦兰德远端肌病。我们的病例报告强调了对患者进行电诊断和基因检测的重要性。